drugset / Trial / NCT05425355

Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult Patients

NCT05425355 ↗

Phase 4 Recruiting 42 enrolled University Health Network, Toronto
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The INTACT-HIP trial study will evaluate feasibility of conducting a randomized, double-blinded controlled trial comparing postoperative treatment with intravenous (IV) acetaminophen versus oral acetaminophen, in older adults undergoing hip fracture surgery. The results of this feasibility trial will be used to inform designing a larger, multi-center, randomized controlled trial to assess the efficacy of IV acetaminophen compared to oral acetaminophen to reduce delirium and improve other clinical and patient-centered outcomes after hip fracture surgery. It will randomize 42 older adults to receive either oral or IV acetaminophen after hip fracture surgery.

Timeline

Start
2023-01-23
Primary completion
2025-12-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule — Intravenous

Indications